JP2010512306A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512306A5 JP2010512306A5 JP2009534723A JP2009534723A JP2010512306A5 JP 2010512306 A5 JP2010512306 A5 JP 2010512306A5 JP 2009534723 A JP2009534723 A JP 2009534723A JP 2009534723 A JP2009534723 A JP 2009534723A JP 2010512306 A5 JP2010512306 A5 JP 2010512306A5
- Authority
- JP
- Japan
- Prior art keywords
- region
- polypeptide
- sialic acid
- polysaccharide chain
- unpurified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 38
- 102000004196 processed proteins & peptides Human genes 0.000 claims 38
- 108090000765 processed proteins & peptides Proteins 0.000 claims 38
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims 14
- 150000004676 glycans Polymers 0.000 claims 14
- 150000004804 polysaccharides Polymers 0.000 claims 14
- 125000005629 sialic acid group Chemical group 0.000 claims 13
- 238000000034 method Methods 0.000 claims 8
- 239000003814 drug Substances 0.000 claims 7
- 230000009450 sialylation Effects 0.000 claims 7
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 230000003110 anti-inflammatory effect Effects 0.000 claims 5
- 229940079593 drug Drugs 0.000 claims 5
- 230000003013 cytotoxicity Effects 0.000 claims 3
- 231100000135 cytotoxicity Toxicity 0.000 claims 3
- 108090000790 Enzymes Proteins 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 102000003838 Sialyltransferases Human genes 0.000 claims 2
- 108090000141 Sialyltransferases Proteins 0.000 claims 2
- 229930182830 galactose Natural products 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 150000007523 nucleic acids Chemical group 0.000 claims 2
- 108020003175 receptors Proteins 0.000 claims 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 claims 2
- 108010021468 Fc gamma receptor IIA Proteins 0.000 claims 1
- 108010021470 Fc gamma receptor IIC Proteins 0.000 claims 1
- 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 claims 1
- 102100029206 Low affinity immunoglobulin gamma Fc region receptor II-c Human genes 0.000 claims 1
- 102100029193 Low affinity immunoglobulin gamma Fc region receptor III-A Human genes 0.000 claims 1
- 101710099301 Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims 1
- 230000004988 N-glycosylation Effects 0.000 claims 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims 1
- 230000003213 activating effect Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 201000008383 nephritis Diseases 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 206010043554 thrombocytopenia Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2006/041791 WO2007055916A2 (en) | 2005-11-07 | 2006-10-27 | Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof |
| PCT/US2007/008396 WO2007117505A2 (en) | 2006-04-05 | 2007-04-03 | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| PCT/US2007/072771 WO2008057634A2 (en) | 2006-10-26 | 2007-07-03 | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010512306A JP2010512306A (ja) | 2010-04-22 |
| JP2010512306A5 true JP2010512306A5 (enExample) | 2012-08-16 |
Family
ID=40792829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009534723A Pending JP2010512306A (ja) | 2006-10-27 | 2007-07-03 | 抗炎症特性が増強され、細胞毒性特性が減少したポリペプチドおよび関連する方法 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2010512306A (enExample) |
| CA (1) | CA2666308C (enExample) |
| IL (1) | IL197920A0 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR085302A1 (es) * | 2011-02-24 | 2013-09-18 | Sanofi Sa | Metodo de produccion de anticuerpos sialilados |
| UY34317A (es) | 2011-09-12 | 2013-02-28 | Genzyme Corp | Anticuerpo antireceptor de célula T (alfa)/ß |
| US9790268B2 (en) | 2012-09-12 | 2017-10-17 | Genzyme Corporation | Fc containing polypeptides with altered glycosylation and reduced effector function |
| RU2711935C2 (ru) | 2013-03-11 | 2020-01-23 | Джензим Корпорейшн | Сайт-специфическая конъюгация антитело-лекарственное средство посредством гликоинженерии |
| PL3129067T3 (pl) | 2014-03-19 | 2023-05-08 | Genzyme Corporation | Specyficzne dla miejsca glikomodyfikowanie ugrupowań celujących |
| MA55529A (fr) | 2019-04-03 | 2022-02-09 | Genzyme Corp | Polypeptides de liaison anti-alpha bêta tcr à fragmentation réduite |
| KR102549282B1 (ko) * | 2019-11-18 | 2023-06-30 | 건국대학교 산학협력단 | 시알산화된 면역글로불린을 유효성분으로 포함하는 염증성 질환의 치료용 조성물 |
| CN116705170A (zh) * | 2023-05-08 | 2023-09-05 | 宁波市医疗中心李惠利医院 | 基于maldi-tof ms联合lstm的大肠埃希菌菌株水平鉴定方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ336780A (en) * | 1997-01-16 | 2000-12-22 | Neose Technologies Inc | In vitro sialylation of glycoproteins |
| CN100457914C (zh) * | 1999-04-15 | 2009-02-04 | 荷兰克鲁塞尔公司 | 用编码腺病毒e1蛋白的序列在人体细胞中生产重组蛋白 |
| WO2002030954A1 (en) * | 2000-10-06 | 2002-04-18 | Kyowa Hakko Kogyo Co., Ltd. | Method of purifying antibody |
-
2007
- 2007-07-03 JP JP2009534723A patent/JP2010512306A/ja active Pending
- 2007-07-03 CA CA2666308A patent/CA2666308C/en active Active
-
2009
- 2009-04-05 IL IL197920A patent/IL197920A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009532477A5 (enExample) | ||
| Gunn et al. | A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus | |
| Nagae et al. | Function and 3D structure of the N-glycans on glycoproteins | |
| TWI835772B (zh) | Il-22fc融合蛋白及使用方法 | |
| Czajkowsky et al. | Fc‐fusion proteins: new developments and future perspectives | |
| CN1894275B (zh) | 模仿人epo的铰链核心模仿体、组合物、方法和用途 | |
| Sun et al. | Core fucosylation regulates the function of pre-BCR, BCR and IgG in humoral immunity | |
| Webster et al. | Post-translational modification of plant-made foreign proteins; glycosylation and beyond | |
| EP3728570B1 (en) | Glycoengineering | |
| Ligtenberg et al. | Deleted in malignant brain tumors-1 protein (DMBT1): a pattern recognition receptor with multiple binding sites | |
| US20120134984A1 (en) | Molecules with extended half-lives and uses thereof | |
| JP2009520503A5 (enExample) | ||
| JP2006526414A5 (enExample) | ||
| JP2010004891A (ja) | 改変されたトランスフェリン融合タンパク質 | |
| JP2006504406A (ja) | 哺乳動物のｃｈ１欠失ミメティボディ、組成物、方法および使用 | |
| TW200839012A (en) | Modified soluble FGF receptor Fc fusions with improved biological activity | |
| CN108743967A (zh) | 含有免疫球蛋白fc区作为载体的药物组合物 | |
| JP2009508476A5 (enExample) | ||
| AU7328891A (en) | C4 binding protein fusion proteins | |
| CN112839952A (zh) | 包含基于pd-1的嵌合蛋白的组合疗法 | |
| Anand et al. | Understudied factors influencing Fc-mediated immune responses against viral infections | |
| CN107979973A (zh) | Fc融合蛋白质的转基因生产 | |
| JP2010512306A (ja) | 抗炎症特性が増強され、細胞毒性特性が減少したポリペプチドおよび関連する方法 | |
| US20240109954A1 (en) | Fc-enhanced antibodies for prevention and treatment of ebola virus infection | |
| Bolton et al. | Separation of nonfucosylated antibodies with immobilized FcγRIII receptors |